Cas:1247-97-8 3,5,7,3′,4′-Pentamethoxyflavone manufacturer & supplier

We serve Chemical Name:3,5,7,3′,4′-Pentamethoxyflavone CAS:1247-97-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3,5,7,3′,4′-Pentamethoxyflavone

Chemical Name:3,5,7,3′,4′-Pentamethoxyflavone
CAS.NO:1247-97-8
Synonyms:Pentamethoxyquercetin;Pentamethylquercetin;quercetin 3,5,7,3′,4′-pentamethyl ether;quercetin pentamethyl ether;Penta-O-methylquercitin;Quercetin-3,5,7,3′,4′-pentamethylether
Molecular Formula:C20H20O7
Molecular Weight:372.36900
HS Code:2914509090

Physical and Chemical Properties:
Melting point:152-156ºC
Boiling point:561.9ºC at 760 mmHg
Density:1.29 g/cm3
Index of Refraction:1.588
PSA:76.36000
Exact Mass:372.12100
LogP:3.50300

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Pentamethoxyquercetin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Quercetin-3,5,7,3′,4′-pentamethylether physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Quercetin-3,5,7,3′,4′-pentamethylether Use and application,Pentamethoxyquercetin technical grade,usp/ep/jp grade.


Related News: Travel alerts: As the Wuhan coronavirus spreads around China, infecting more people, a number of countries have raised their travel advisory warnings. 3,5,7,3′,4′-Pentamethoxyflavone manufacturer What’s the background? 3,5,7,3′,4′-Pentamethoxyflavone supplier Travel alerts: As the Wuhan coronavirus spreads around China, infecting more people, a number of countries have raised their travel advisory warnings. 3,5,7,3′,4′-Pentamethoxyflavone vendor Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037. 3,5,7,3′,4′-Pentamethoxyflavone factory Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037.